Understanding membrane interactions and cell-wall permeation of Gram-negative bacteria is of great importance due to increasing bacterial resistance to existing drugs and therapeutic and LPS binding but also affects penetration into the inner bilayer core. The addition of the Ala 6 peptide moiety, however, does not significantly promote peptide insertion into the hydrophobic lipid environment. The data also indicate that the extent of penetration into the lipid bilayer is not related to the overall affinity of the peptides to the membrane.
Introduction
The emergence of bacterial strains resistant to conventional antibiotics is a major cause for inefficient therapy and increased mortality from bacterial infection. These phenomena have led to intensive efforts aiming for development of novel drugs targeting the bacterial cell membranes. Gram-negative bacteria like E.coli have two cell envelope membranes. The inner, cytoplasmatic membrane consists primarily of phospholipids, while the outer membrane is an asymmetric membrane composed mainly of lipopolysaccharide (LPS) and glycolipids in the outer monolayer, and phospholipids (with a composition similar to that of the cytoplasmic membrane) in its inner monolayer [1, 2] . LPS plays a major role in conferring resistance of Gram-negative bacteria toward toxic agents, most likely by participating in the formation of an effective permeability barrier at the outer membrane. Several hypotheses have been presented to explain the unique permeability properties of LPS, utilizing various structural differences between LPS and phospholipids. Existing models variably identify the biological determinants of LPS in its hydrophobic core [3] , head-groups [4] , or other factors.
in order to examine the effects of a mildly hydrophobic peptidic sequence [14] . Previous studies have detected distinct differences in the biological properties and membrane permeation of those peptides (Table 1) , although all have insignificant antibacterial activities compared to PMB [12] [13] [14] .
In this study we analyzed lipid binding and membrane penetration of the PMBN derivatives. Molecular and structural information on membrane interactions of the PMBN derivatives have been obtained here through application of a newly -developed biomimetic lipid/polydiacetylene (PDA) membrane assay [15] [16] [17] . The lipid/PDA platform consists of vesicles composed of interspersed natural lipids and polymerized PDA which undergo rapid blue-red transitions induced by interactions with varied biological molecules. Previous studies of the biophysical properties of lipid/PDA vesicles indicate that the lipids and polydiacteylene form interspersed, interacting microscopic phases [18] [19] [20] [21] . Importantly, the phospholipids incorporated within the PDA matrix adopt a bilayer structure, the dominant lipid organization within cellular membranes [21] . Published data further point to the contribution of changes in fluidity within the lipid domains for induction of the blue-red transitions [15, 21] .
We have previously demonstrated that PDA-based vesicles could be used for studying membrane processes such as peptide-membrane interactions [15, 16, 22] , membrane permeation by penetration enhancers [18] , and biological recognition events occurring at membrane interfaces [17] . Of particular importance in the context of this study, the polymeric PDA matrix which forms the scaffold of the mixed vesicles can incorporate different lipid components while maintaining its overall sensitivity to membrane properties and processes [21, 22] . In this work, application of lipid binding measurements, colorimetric analysis, and spectroscopic techniques such as fluorescence quenching and electron spin resonance (ESR) sheds light upon membrane interactions of the PMB derivatives and their permeation properties.
Experimental

Materials.
Phospholipids, including dimyristoylphosphatidylcholine (DMPC),
dimyristoylphosphatidylglycerol (DMPG), and lipopolysaccharides (LPS) (Escherichia coli
055:B5) were purchased from Sigma. LPS was dialyzed in EDTA (Sigma) (1mM, 24h) solution followed by distilled water in order to remove excess divalent cations (which generally cause precipitation of lipid/PDA vesicles). The diacetylenic monomer 10,12-tricosadiynoic acid was purchased from GFS Chemicals (Powell, OH), washed in chloroform, and filtered through a 0.45 µm filter prior to use.
Polymyxin B (PMB)-sulfate was purchased from Sigma. Synthesis and purification of the PMB derivatives is described elsewhere [12] [13] [14] . The more abundant alamethicin homolog containing glutamic acid at position 18 (AibPAibAAibAQAibVAibGLAibPVAibAibEQF-OH (where Aib denotes alpha-amino isobutyric acid) was used (Sigma).
Vesicle Preparation. Preparation of vesicles containing lipid components and PDA (DMPG/DMPC/PDA -1:1:3 mole ratio, LPS/DMPC/PDA -0.2:2:3 ratio) was carried out as the following: All lipid constituents were dissolved in chloroform/ethanol (1:1) and dried together in vacuo up to constant weight, followed by addition of deionized water and probe sonication at 70°C for 2-3 minutes. The vesicle solution was then cooled at room temperature and was kept at 4°C overnight. The vesicles were then polymerized using irradiation at 254 nm for 10-20 sec, with the resulting solutions exhibiting an intense blue appearance.
Dansyl-PMBN displacement assay. The fluorescence of dansyl-PMBN bound to vesicles was measured at 28°C using an SLM Aminco Bowman spectrofluorimeter with excitation at 340 nm and emission acquired at 485 nm. Increasing quantities of dansyl-PMBN (1×10 -5 M -
1×10
-3 M) were added to a quartz cuvette containing vesicle solution (7.5µL, 1mM) and buffer (7.5µL Tris-base 50mM, pH 8). The solution was diluted to 1 mL with distilled water and fluorescence was recorded. The fluorescence of vesicle-bound dansyl-PMBN (1×10 -4 M) was determined at 85% of maximum fluorescence, which served as the control sample. The decrease in dansyl-PMBN fluorescence (percent decrease from control) as a result of progressive addition of peptides was then measured.
Determination of partition coefficients.
Calibration graphs for determination of concentrations of the soluble peptides were initially constructed using the Lowry method [23] .
The calibration graphs were employed to evaluate the concentrations of peptides unbound to the lipid/PDA vesicles. Increasing peptide quantities were added to aqueous lipid/PDA vesicle solutions (0.5mM, Tris buffer 25mM at pH 8), the solutions were left at room temperature for a few minutes to allow equilibration and were centrifuged at 30000 rpm for 40 min in order to precipitate the vesicle-peptide aggregates. The concentration of soluble (unbound) peptide in the supernatant was determined from the calibration curve, and was subtracted from the initial concentration to yield the amount of bound peptide.
Uv-vis measurements. Samples were prepared by adding peptides (at final concentrations of between 5-100 µM) to 0.06 mL vesicle solutions at 0.5 mM total lipid concentration and 25mM Tris (pH 8). The PMBN derivatives were dissolved in water (in the synergy experiments alamethicin was dissolved in TFE). Following addition of the peptides, the solutions were diluted to 1 mL and uv-vis spectra were acquired. Uv-vis spectroscopy measurements were carried out at 28°C on a Jasco V-550 spectrophotometer, using a 1 cm optical path cell.
A quantitative value for the extent of the blue-to-red color transitions within the vesicle solutions is given by the colorimetric response (%CR), which is defined as follows [24] :
A is the absorbance either at the "blue" component in the uv-vis spectrum (640 nm) or at the "red" component (500 nm). (Note: "blue" and "red" refer to the visual appearance of the material, not its actual absorbance). PB 0 is the blue/red ratio of the control sample (before induction of a color change), and PB I is the value obtained for the vesicle solution after colorimetric transition occurs. 
Electron spin resonance (ESR).
Samples for the ESR experiments were prepared using the spin label 5-doxyl-stearic acid (5-DS, Sigma). 5-DS was added to the vesicle samples after the polymerization step in a molar ratio of 1:100 (spin label : lipids). Samples were placed in a 20 mm length, 1 mm internal-diameter quartz capillary and recorded using a Bruker EMX-220 digital X-band spectrometer operating at room temperature. The amplitudes of 12.5 kHz and 100 kHz modulation and the microwave power level were chosen at sub-critical values (0.5 G and 10 mW, respectively) to reach the best signal-to-noise ratio. Processing of the ESR spectra (digital filtering, double integration, etc.) was carried out using Bruker WIN-EPR software.
Results
Membrane interactions of PMB and PMBN: synergy experiments. An important biological characteristic of both PMB and its PMBN derivative is the facilitation of membrane penetration for varied chemical and biological molecules through synergistic effects [12] [13] [14] .
The penetration synergy has been ascribed to the strong interactions of the peptides with the LPS head-groups, thus reducing the permeation barrier of bacterial outer membranes [25] [26] [27] .
We have examined whether synergy effects are also observed for PMB and PMBN interactions with the bio-mimetic LPS/DMPC/PDA chromatic vesicles (Figure 2 ). We chose to examine the synergy effects specifically only for PMB, the parent molecule, and PMBN, the generic derivative, for which biological synergies were previously determined [26, 27] . Table 2 ), followed by a plateau corresponding to the maximal concentration of vesicle-bound peptide (the binding capacity).
The data depicted in Figure 4 and Table 2 reveal distinct differences in the binding profiles of the peptides. PMB exhibits a stoichiometric ratio closer to unity between bound and total peptide concentrations ( Figure 4A and Table 2 ), which indicates the highest affinity amongst all peptides to the two vesicle models, similar to the results of the dansyl-PMBN displacement assay discussed above (Figure 3 ). In addition, the binding curves of PMB in Table 2 ). However, the partition coefficients recorded for those analogs are again significantly lower than PMB (Table 2) indicating lesser affinities of PMBN and dPMBN to the lipid bilayers and consistent with the lower biological activities of the analogs in relation to PMB (Table 1) . Interestingly, Ala 6 -PMBN ( Figure 4D ) seems to bind with almost identical affinities of around 0.5 onto both vesicle compositions. This result suggests that the peptidic side-chain is also affecting the binding of the Ala 6 -PMBN analog to the LPScontaining bacterial outer membrane. Figure 5A ) and LPS/DMPC/PDA vesicles ( Figure 5B ). The compositions of these lipid/PDA models were selected in order to examine the effects of lipid type on membrane interactions of the peptides. Accurate interpretation of the colorimetric data requires calculations of the color transitions induced only by vesicle-bound peptides, rather than the total peptide concentration (which includes also unbound peptide in the aqueous solution [16, 18] ). Thus, the curves shown in Figure 5 take into account the relative partition coefficients of the peptides with the lipid/PDA vesicles, calculated using the centrifugation binding assay described above ( Figure 4 and Table 2 ). The colorimetric curves shown in Figure 5 exhibit an initial increase in %CR, and reach values of between %CR of 60%-80% corresponding to maximal red color induced by the bound peptides. In general, the informative part of the colorimetric curves constitutes the slopes prior to saturation [15, 16] .
Examination of Figure 5 reveals both similarities as well as distinct differences in membrane interactions of the peptides. In both vesicle models the steepest colorimetric response (%CR) curve (i.e. greater blue-red transitions in relation to peptide concentration) is observed for dPMBN, for which 60% CR is attained after addition of less than 15 µM peptide concentration ( Figure 5A,B) . We have previously demonstrated that a relatively steep increase in %CR vs. concentration is indicative of a pronounced perturbation of the lipid head-group region [16] . Accordingly, the colorimetric data suggest that dPMBN mostly binds at the lipid/water interface rather than penetrates into the hydrophobic core of the lipid bilayer. In comparison to dPMBN which resides at the lipid surface, PMBN and Ala 6 -PMBN both induce less %CR (per peptide concentrations) indicating deeper penetration into the lipid domains ( Figure 5A ,B). However a difference appears between the behavior of PMBN and Ala 6 -PMBN in the two vesicle compositions. Specifically, in DMPG/DMPC/PDA vesicles, the %CR curves of the two analogs are almost coincident ( Figure 5A ), while in the LPS/DMPC/PDA assembly Ala 6 -PMBN induces higher %CR than PMBN ( Figure 5B ). This result suggests greater interfacial interaction for Ala 6 -PMBN.
The colorimetric analysis further points to the specific role of LPS in eliciting surface interaction of the PMBN analogs ( Figure 5C ). The bar diagram in Figure 5C example, gave rise to the highest quenching among the analogs both in DMPG/DMPC/PDA vesicles (less than 50% fluorescence observed after 2 min., Figure 6A ) and LPS/DMPC/PDA vesicles (around 45% signal at 2 min., Figure 6B ). This result is indicative of the pronounced association of the peptide at the lipid/water interface, which allows the soluble dithionite easier access to the NBD moieties located closer to the lipid bilayer surface. This interpretation is fully consistent with the colorimetric data discussed above ( Figure 5 ).
Slower fluorescence quenching was recorded for PMBN and Ala 6 -PMBN, albeit differences are observed between the two vesicle systems. PMBN gave rise to a relatively slow quenching -60% signal after 120 sec in NBD-PE/DMPG/DMPC/PDA and 70% in NBD-PE/LPS/DMPC/PDA vesicles (curve ii, Figure 6 ), consistent with the lesser head-group disruption by this peptide inferred from the colorimetric analysis ( Figure 5) . Similarly, Ala 6 -PMBN induced stronger quenching in the NBD-PE/LPS/DMPC/PDA vesicle system (curve iii, Figure 6B ) explained by the more pronounced interfacial association of this analog in the LPS-containing bilayers.
The quenching rate of the parent peptide PMB was the slowest among the peptide examined in the two vesicle systems (curve i, Figure 6 ). This result might correspond to a lesser interfacial localization of PMB compared to its analogs. Deeper penetration of PMB into the bilayer in the LPS-containing vesicles was also inferred from the colorimetric analysis (figure 5, above). The slowest quenching rate induced by PMB in the NBD-PE/DMPG/DMPC/PDA vesicles (curve i, Figure 6A ESR data, acquired using phospholipid/PDA vesicles incorporating stearic acid to which the doxyl spin label is covalently attached in carbon position 5 in the acyl chain (denoted 5-DS), illuminate the dynamical effects of peptide binding onto the lipid moieties within the lipid/PDA vesicles (Table 3) . Spin-labeled lipid probes have been extensively used as a tool for probing the organization and local motion within lipid membranes [36, 37] . The molar ratio of 100:1 (lipids : spin-label) employed in the experiments described here does not alter the properties and organization of the phospholipid/PDA vesicles. In particular, the colorimetric transformations of the vesicles were not affected by addition of the spin label [15] . Table 3 outlines the values of the parallel hyperfine splitting parameter A`z z obtained from the ESR spectra of 5-DS labels incorporated within the two lipid vesicle models following addition of the different PMBN analogs. It is generally recognized that the A`z z parameter reflects the spin label dynamics within the slow motion region [36] . The ESR results in Table 3 indicate that the PMB derivatives modify the dynamical properties of the lipid moieties. In all samples the peptides gave rise to significantly higher A`z z values of the doxyl label -corresponding to greater rigidity of the lipid domains surrounding the spin label [36] . Importantly, these changes in the A`z z splitting of 5-DS seem to parallel the colorimetric transitions induced by the peptides ( Figure 5 ) and the fluorescence quenching data ( Figure 6 ). dPMBN, for example, induces pronounced stiffening of the lipid assembly both in DMPG/DMPC/PDA vesicles (A`z z = 5.49) and in LPS/DMPC/PDA vesicles (A`z z = 5.57, Table 3 ). These data are consistent with the binding of dPMBN at the lipid/water interface because the spin label in 5-DS is adjacent to the lipid head-group region. The ESR results recorded for Ala 6 -PMBN also corroborate the colorimetric and fluorescence data. properties of dPMBN and PMBN but the almost complete biological inactivation of dPMBN [13] . In addition to the essential functional role of the PMBN ring, the data testified to an involvement of the mildly hydrophobic Ala 6 peptidic side-chain in lipid interactions, particularly in binding at the lipid/water interface. Due to its long lipophilic peptide residue, Ala 6 -PMBN was expected to penetrate relatively deeply into the lipid core. However, significant interfacial perturbation rather than penetration was detected when LPS was present within the lipid assembly ( Figures 5-6 and Table 3 ). The effect of Ala 6 -PMBN on the headgroup region of LPS/DMPC/PDA appeared even stronger than PMBN. This result attests to the fact that the side-chain, and not only the cyclic moiety, contributes to interactions with the LPS head-group and participates in molecular rearrangement closer to the lipid/water interface.
The experiments seem to underscore important molecular aspects pertaining to the outer membrane permeation and lytic activity of PMB. The colorimetric assay indicates that the parent peptide induces perturbation both at the lipid/water interface as well as deeper within the hydrophobic interior of the membrane. The experimental observations indeed suggest that the potent biological effects of PMB, specifically its membrane permeation properties and high toxicity, are related to its ability to disrupt both lipid head-groups as well as the hydrophobic domains of the membrane. This interpretation could also explain the generally lower permeation and reduced lytic activities of the molecules derived from PMB; alteration of either the ring or the terminal acyl residue might interfere with the capabilities of the peptide to penetrate and disrupt cellular membranes.
The experiments presented here could underscore distinct molecular aspects pertaining to the outer membrane permeation and lytic activities of PMB and its derivatives. 
